Therapeutics based on small interfering RNA (siRNA) have a huge potential for the treatment of disease but requires sophisticated delivery systems for in vivo applications. Lipid nanoparticles (LNP) are proven delivery systems for conventional small molecule drugs with over eight approved LNP drugs.
β¦ LIBER β¦
Lipid nanoparticle delivery systems for siRNA-based therapeutics
β Scribed by C. Wan, T. M. Allen, P. R. Cullis
- Book ID
- 120722075
- Publisher
- Springer-Verlag
- Year
- 2013
- Tongue
- English
- Weight
- 612 KB
- Volume
- 4
- Category
- Article
- ISSN
- 2190-393X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lipid nanoparticle delivery systems for
β
C. Wan, T. M. Allen, P. R. Cullis
π
Article
π
2013
π
Springer-Verlag
π
English
β 612 KB
Delivery Technologies for Biopharmaceuti
β
Jorgensen, Lene; Nielsen, Hanne Mrck
π
Article
π
2009
π
John Wiley & Sons, Ltd
π
English
β 155 KB
Advances in biotechnology have provided scientists with an increasing number of biopharmaceuticals such as novel peptide and protein drugs as well as nucleic acid based drugs for gene therapy. However, successful delivery of these biopharmaceuticals is a major challenge because their molecular prope
Lipid-based nanotherapeutics for siRNA d
β
A. Schroeder; C. G. Levins; C. Cortez; R. Langer; D. G. Anderson
π
Article
π
2010
π
John Wiley and Sons
π
English
β 410 KB
Biodegradable calcium phosphate nanopart
β
Jun Li; Yun-Ching Chen; Yu-Cheng Tseng; Subho Mozumdar; Leaf Huang
π
Article
π
2010
π
Elsevier Science
π
English
β 946 KB
Lipid-Based Nanoparticles for siRNA Deli
β
Gomes-da-Silva, LΓgia C.; Fonseca, Nuno A.; Moura, Vera; Pedroso de Lima, Maria
π
Article
π
2012
π
American Chemical Society
π
English
β 368 KB
Cell-penetrating peptide-conjugated lipi
β
Asai, Tomohiro; Tsuzuku, Takuma; Takahashi, Shoya; Okamoto, Ayaka; Dewa, Takehis
π
Article
π
2014
π
Elsevier Science
π
English
β 518 KB